Michael Racke
Michael Racke
Professor of Neurology, Ohio State University
Verified email at osumc.edu
Title
Cited by
Cited by
Year
Multiple sclerosis—the plaque and its pathogenesis
EM Frohman, MK Racke, CS Raine
New England Journal of Medicine 354 (9), 942-955, 2006
19642006
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
MK Racke, A Bonomo, DE Scott, B Cannella, A Levine, CS Raine, ...
The Journal of experimental medicine 180 (5), 1961-1966, 1994
7311994
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
JM Critchfield, MK Racke, JC Zuniga-Pflucker, B Cannella, CS Raine, ...
Science 263 (5150), 1139-1143, 1994
6091994
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement
MS Freedman, EJ Thompson, F Deisenhammer, G Giovannoni, ...
Archives of neurology 62 (6), 865-870, 2005
5942005
Immune surveillance in multiple sclerosis patients treated with natalizumab
O Stüve, CM Marra, KR Jerome, L Cook, PD Cravens, S Cepok, ...
Annals of Neurology: Official Journal of the American Neurological …, 2006
4632006
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
MK Racke, S Dhib-Jalbut, B Cannella, PS Albert, CS Raine, DE McFarlin
The Journal of Immunology 146 (9), 3012-3017, 1991
4371991
Peroxisome proliferator-activated receptor-γ agonist 15-deoxy-Δ12, 1412, 14-prostaglandin J2 ameliorates experimental autoimmune encephalomyelitis
A Diab, C Deng, JD Smith, RZ Hussain, B Phanavanh, AE Lovett-Racke, ...
The Journal of Immunology 168 (5), 2508-2515, 2002
3632002
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
K Ghoreschi, J Brück, C Kellerer, C Deng, H Peng, O Rothfuss, ...
Journal of Experimental Medicine 208 (11), 2291-2303, 2011
3602011
Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
MK Racke, D Burnett, SH Pak, PS Albert, B Cannella, CS Raine, ...
The Journal of Immunology 154 (1), 450-458, 1995
3291995
Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.
AE Lovett-Racke, JL Trotter, J Lauber, PJ Perrin, CH June, MK Racke
The Journal of clinical investigation 101 (4), 725-730, 1998
3111998
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay
MP Crawford, SX Yan, SB Ortega, RS Mehta, RE Hewitt, DA Price, ...
blood 103 (11), 4222-4231, 2004
3062004
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
Y Yang, J Weiner, Y Liu, AJ Smith, DJ Huss, R Winger, H Peng, ...
Journal of Experimental Medicine 206 (7), 1549-1564, 2009
3052009
T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity
AR Gocke, PD Cravens, LH Ben, RZ Hussain, SC Northrop, MK Racke, ...
The Journal of Immunology 178 (3), 1341-1348, 2007
3002007
Factors that influence adherence with disease-modifying therapy in MS
K Treadaway, G Cutter, A Salter, S Lynch, J Simsarian, J Corboy, ...
Journal of neurology 256 (4), 568-576, 2009
2992009
IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease
M Röcken, M Racke, EM Shevach
Immunology today 17 (5), 225-231, 1996
2961996
CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.
PJ Perrin, JH Maldonado, TA Davis, CH June, MK Racke
The Journal of Immunology 157 (4), 1333-1336, 1996
2891996
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis
O Stüve, CM Marra, A Bar-Or, M Niino, PD Cravens, S Cepok, ...
Archives of neurology 63 (10), 1383-1387, 2006
2812006
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
EM Frohman, DS Goodin, PA Calabresi, JR Corboy, PK Coyle, M Filippi, ...
Neurology 61 (5), 602-611, 2003
2712003
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
R Zivadinov, AT Reder, M Filippi, A Minagar, O Stüve, H Lassmann, ...
Neurology 71 (2), 136-144, 2008
2592008
The relationship between diffuse axonal damage and fatigue in multiple sclerosis
MC Tartaglia, S Narayanan, SJ Francis, AC Santos, N De Stefano, ...
Archives of neurology 61 (2), 201-207, 2004
2422004
The system can't perform the operation now. Try again later.
Articles 1–20